A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
Clinical trial NCT05764590 · COMPLETED
Trial details
- NCT number
- NCT05764590
- Sponsor
- Alebund Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2023-08-25
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.